Discontinuation of anti-tumour necrosis factor alpha treatment owing to blood test abnormalities, and cost-effectiveness of alternate blood monitoring strategies.
Saved in:
| Title: | Discontinuation of anti-tumour necrosis factor alpha treatment owing to blood test abnormalities, and cost-effectiveness of alternate blood monitoring strategies. |
|---|---|
| Authors: | Abhishek A; Academic Rheumatology., Stevenson MD; School of Health and Related Research, University of Sheffield, Sheffield, UK., Nakafero G; Academic Rheumatology., Grainge MJ; Lifespan and Population Health., Evans I; BADBIR, University of Manchester, Manchester, UK., Alabas O; BADBIR, University of Manchester, Manchester, UK., Card T; Lifespan and Population Health., Taal MW; Centre for Kidney Research and Innovation, Translational Medical Sciences, University of Nottingham, Derby, UK., Aithal GP; Nottingham Digestive Diseases Centre, Translational Medical Sciences, University of Nottingham, Nottingham, UK., Fox CP; Centre for Cancer Studies, Translational Medical Sciences, School of Medicine, University of Nottingham, Derby, UK., Mallen CD; Primary Care Centre Versus Arthritis, Keele University, Keele, UK., van der Windt DA; Primary Care Centre Versus Arthritis, Keele University, Keele, UK., Riley RD; Institute of Applied Health Research, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK., Warren RB; Dermatology Centre, Northern Care Alliance NHS Foundation Trust, Manchester, UK.; NIHR Manchester Biomedical Research Centre, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK., Williams HC; Lifespan and Population Health. |
| Source: | The British journal of dermatology [Br J Dermatol] 2024 Mar 15; Vol. 190 (4), pp. 559-564. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Oxford University Press Country of Publication: England NLM ID: 0004041 Publication Model: Print Cited Medium: Internet ISSN: 1365-2133 (Electronic) Linking ISSN: 00070963 NLM ISO Abbreviation: Br J Dermatol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 37931161 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Discontinuation of anti-tumour necrosis factor alpha treatment owing to blood test abnormalities, and cost-effectiveness of alternate blood monitoring strategies. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Abhishek+A%22">Abhishek A</searchLink>; Academic Rheumatology.<br /><searchLink fieldCode="AU" term="%22Stevenson+MD%22">Stevenson MD</searchLink>; School of Health and Related Research, University of Sheffield, Sheffield, UK.<br /><searchLink fieldCode="AU" term="%22Nakafero+G%22">Nakafero G</searchLink>; Academic Rheumatology.<br /><searchLink fieldCode="AU" term="%22Grainge+MJ%22">Grainge MJ</searchLink>; Lifespan and Population Health.<br /><searchLink fieldCode="AU" term="%22Evans+I%22">Evans I</searchLink>; BADBIR, University of Manchester, Manchester, UK.<br /><searchLink fieldCode="AU" term="%22Alabas+O%22">Alabas O</searchLink>; BADBIR, University of Manchester, Manchester, UK.<br /><searchLink fieldCode="AU" term="%22Card+T%22">Card T</searchLink>; Lifespan and Population Health.<br /><searchLink fieldCode="AU" term="%22Taal+MW%22">Taal MW</searchLink>; Centre for Kidney Research and Innovation, Translational Medical Sciences, University of Nottingham, Derby, UK.<br /><searchLink fieldCode="AU" term="%22Aithal+GP%22">Aithal GP</searchLink>; Nottingham Digestive Diseases Centre, Translational Medical Sciences, University of Nottingham, Nottingham, UK.<br /><searchLink fieldCode="AU" term="%22Fox+CP%22">Fox CP</searchLink>; Centre for Cancer Studies, Translational Medical Sciences, School of Medicine, University of Nottingham, Derby, UK.<br /><searchLink fieldCode="AU" term="%22Mallen+CD%22">Mallen CD</searchLink>; Primary Care Centre Versus Arthritis, Keele University, Keele, UK.<br /><searchLink fieldCode="AU" term="%22van+der+Windt+DA%22">van der Windt DA</searchLink>; Primary Care Centre Versus Arthritis, Keele University, Keele, UK.<br /><searchLink fieldCode="AU" term="%22Riley+RD%22">Riley RD</searchLink>; Institute of Applied Health Research, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.<br /><searchLink fieldCode="AU" term="%22Warren+RB%22">Warren RB</searchLink>; Dermatology Centre, Northern Care Alliance NHS Foundation Trust, Manchester, UK.; NIHR Manchester Biomedical Research Centre, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK.<br /><searchLink fieldCode="AU" term="%22Williams+HC%22">Williams HC</searchLink>; Lifespan and Population Health. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%220004041%22">The British journal of dermatology</searchLink> [Br J Dermatol] 2024 Mar 15; Vol. 190 (4), pp. 559-564. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Oxford+University+Press%22">Oxford University Press </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>0004041 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1365-2133 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200070963%22">00070963 </searchLink><i>NLM ISO Abbreviation: </i>Br J Dermatol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37931161 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1093/bjd/ljad430 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 559 Titles: – TitleFull: Discontinuation of anti-tumour necrosis factor alpha treatment owing to blood test abnormalities, and cost-effectiveness of alternate blood monitoring strategies. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Abhishek A – PersonEntity: Name: NameFull: Stevenson MD – PersonEntity: Name: NameFull: Nakafero G – PersonEntity: Name: NameFull: Grainge MJ – PersonEntity: Name: NameFull: Evans I – PersonEntity: Name: NameFull: Alabas O – PersonEntity: Name: NameFull: Card T – PersonEntity: Name: NameFull: Taal MW – PersonEntity: Name: NameFull: Aithal GP – PersonEntity: Name: NameFull: Fox CP – PersonEntity: Name: NameFull: Mallen CD – PersonEntity: Name: NameFull: van der Windt DA – PersonEntity: Name: NameFull: Riley RD – PersonEntity: Name: NameFull: Warren RB – PersonEntity: Name: NameFull: Williams HC IsPartOfRelationships: – BibEntity: Dates: – D: 15 M: 03 Text: 2024 Mar 15 Type: published Y: 2024 Identifiers: – Type: issn-electronic Value: 1365-2133 Numbering: – Type: volume Value: 190 – Type: issue Value: 4 Titles: – TitleFull: The British journal of dermatology Type: main |
| ResultId | 1 |